Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to identify cellular and molecular determinants of response to neoadjuvant immunochemotherapy in women aged 18 or older with early-stage triple-negative breast cance...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Center Eugene Marquis
NCT06767527 · Triple-Negative Breast Cancer (TNBC)
NCT07208149 · Triple-Negative Breast Cancer (TNBC)
NCT07073755 · Metastatic Breast Cancer, Drug Resistance, and more
NCT07509515 · Triple-negative Breast Cancer (TNBC)
NCT06975644 · Triple-Negative Breast Cancer (TNBC), Neoadjuvant Chemotherapy, and more
Centre Eugène Marquis
Rennes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions